Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

NCT02534363 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders

Interventions

DRUG: Aripiprazole
DRUG: Quetiapine
DRUG: Ziprasidone
BEHAVIORAL: Cognitive battery

Sponsor

Fundación Marques de Valdecilla

Collaborators

[object Object]
[object Object]